发明名称 MODULATION OF NEUROGLIA-DERIVED BDNF IN THE TREATMENT AND PREVENTION OF PAIN
摘要 <p>Methods and products for the treatment or prevention of pain and the reduction of nociception are described, comprising the modulation of neuroglia-derived brain-derived neurotrophic factor (BDNF) expression or activity in a mammalian host by the administration of an agent such as the P2X receptor inhibitor, TNP-ATP, a BDNF antisense molecule or BDNF siRNA. Related methods for identifying or characterizing compounds for the treatment or prevention of pain and the reduction of nociception are also described.</p>
申请公布号 WO2006042396(A1) 申请公布日期 2006.04.27
申请号 WO2005CA01501 申请日期 2005.09.30
申请人 UNIVERSITE LAVAL;THE HOSPITAL FOR SICK CHILDREN;COULL, JEFFREY, A., M.;DE KONINCK, YVES;SALTER, MICHAEL;BEGGS, SIMON 发明人 COULL, JEFFREY, A., M.;DE KONINCK, YVES;SALTER, MICHAEL;BEGGS, SIMON
分类号 A61K48/00;A61K31/7076;A61P25/02;A61P25/04;A61P29/02;C12N15/113 主分类号 A61K48/00
代理机构 代理人
主权项
地址